Mark Twain Medical Center | |
768 Mountain Ranch Rd, San Andreas, California 95249 | |
(209) 754-2515 | |
Name | Mark Twain Medical Center |
---|---|
Type | Critical Access Hospital |
Location | 768 Mountain Ranch Rd, San Andreas, California |
Ownership | Voluntary non-profit - Other |
Emergency Services | No |
Medicare ID (CCN) | 051332 |
NPI Number | 1366210478 |
Organization Name | COMMUNITY MEDICAL TEAM ACUTE CARE CORPORATION |
Doing Business As | COMMUNITY MEDICAL TEAM INC |
Address | 768 Mountain Ranch Rd, San Andreas, CA 95249 |
Hospital Type | General Acute Care Hospital |
Phone Number | 209-915-6505 |
News Archive
AstraZeneca announced today that the US Food and Drug Administration (FDA) has approved BRILINTA (ticagrelor) tablets to reduce the rate of heart attack and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel.
Researchers from the National Institutes of Health (NIH) and Cornell University in the U.S. just described several new inhibitors of human coronavirus spike proteins by screening a library of approved drugs with SARS-S and MERS-S pseudotyped particle entry assays. Their exciting findings are currently available on the bioRxiv preprint server.
BMA Scotland today welcomed reports that the Scottish Government intends to reduce the drinking driving limit in Scotland from 80mg per 100ml of blood to 50 mg, a move that could prevent as many as 40 deaths on Scotland's roads every year.
Judge Morris E. Lasker of the U.S. District Court for the District of Massachusetts has granted final approval of a $52.5 million settlement in two separate but related securities class actions against Sepracor Inc., a Massachusetts-based pharmaceutical company.
› Verified 4 days ago
NPI Number | 1508968819 |
Organization Name | MARK TWAIN MEDICAL CENTER |
Address | 768 Mountain Ranch Rd, San Andreas, CA 95249 |
Hospital Type | General Acute Care Hospital |
Phone Number | 209-754-3521 |
News Archive
AstraZeneca announced today that the US Food and Drug Administration (FDA) has approved BRILINTA (ticagrelor) tablets to reduce the rate of heart attack and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel.
Researchers from the National Institutes of Health (NIH) and Cornell University in the U.S. just described several new inhibitors of human coronavirus spike proteins by screening a library of approved drugs with SARS-S and MERS-S pseudotyped particle entry assays. Their exciting findings are currently available on the bioRxiv preprint server.
BMA Scotland today welcomed reports that the Scottish Government intends to reduce the drinking driving limit in Scotland from 80mg per 100ml of blood to 50 mg, a move that could prevent as many as 40 deaths on Scotland's roads every year.
Judge Morris E. Lasker of the U.S. District Court for the District of Massachusetts has granted final approval of a $52.5 million settlement in two separate but related securities class actions against Sepracor Inc., a Massachusetts-based pharmaceutical company.
› Verified 4 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
AstraZeneca announced today that the US Food and Drug Administration (FDA) has approved BRILINTA (ticagrelor) tablets to reduce the rate of heart attack and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel.
Researchers from the National Institutes of Health (NIH) and Cornell University in the U.S. just described several new inhibitors of human coronavirus spike proteins by screening a library of approved drugs with SARS-S and MERS-S pseudotyped particle entry assays. Their exciting findings are currently available on the bioRxiv preprint server.
BMA Scotland today welcomed reports that the Scottish Government intends to reduce the drinking driving limit in Scotland from 80mg per 100ml of blood to 50 mg, a move that could prevent as many as 40 deaths on Scotland's roads every year.
Judge Morris E. Lasker of the U.S. District Court for the District of Massachusetts has granted final approval of a $52.5 million settlement in two separate but related securities class actions against Sepracor Inc., a Massachusetts-based pharmaceutical company.
› Verified 4 days ago
Mark Twain Medical Center Critical Access Hospital Location: 768 Mountain Ranch Rd, San Andreas, California 95249 Phone: (209) 754-2515 |